| Literature DB >> 25738328 |
Islem Younes1, Marguerite Rinaudo2.
Abstract
This review describes the most common methods for recovery of chitin from marine organisms. In depth, both enzymatic and chemical treatments for the step of deproteinization are compared, as well as different conditions for demineralization. The conditions ofEntities:
Mesh:
Substances:
Year: 2015 PMID: 25738328 PMCID: PMC4377977 DOI: 10.3390/md13031133
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structure of chitin and chitosan
Comparison of conditions for chitin production according to literature.
| Source | Deproteinization | Demineralization | References | |||||
|---|---|---|---|---|---|---|---|---|
| NaOH Concentration * | Temperature (°C) | Number of Baths | Duration (h) | HCl Concentration* | Temperature (°C) | Duration (h) | ||
| 12 species of crustaceous and cephalopods | 0.3 M | 80–85 | From 2 to 7 according to the source | 1 h for each bath | 0.55 M | Room | 15 mn to 1 h by bath repeated 2–5 times according to the source | [ |
| Shrimp | 0.125 M | 100 | 1 | 0.5 | 1.25 M | Room | 1 | [ |
| Shrimp | 1.25 M | 100 | 1 | 0.5 | 1.57 M | 20–22 | 1–3 | [ |
| Crab | 0.5 M | 65 | 1 | 2 | 1.57 M | Room | 5 | [ |
| Crab | 1 M | 80 | 1 | 3 | 1 M | Room | 12 | [ |
| Crab | 1 M | 100 | 1 | 36 | 2 M | Room | 48 | [ |
| Crab | 1 M | 100 | 3 | 72 | 1 M | Room | - | [ |
| Crab | 1.25 M | 85–90 | 3 | 24 | 1.37 M | Room | 24 | [ |
| Crab/Lobster | 2.5 M | Room | 3 | 72 | 11 M | −20 | 4 | [ |
| Krill | 0.875 M | 90–95 | 1 | 2 | 0.6 M | Room | 2 | [ |
| Lobster | 1 M | 100 | 5 | 12 | 2 M | Room | 5 | [ |
| Squid | 2 M | Room | 2 | One night | 1 M | Room | One night | [ |
| 2 M | 100 | 4 | ||||||
| Lobster | 10% | 100 | 1 | 2.5 | 10% HCl | Room | 18 | [ |
| Krill | 3.5% | 25 | 1 | 2 | 3.5% | 20 | 1.5 | [ |
| Lobster | 5% | 80–85 | 2 | 0.5 | 5% | 70 | 4 | [ |
| Crawfish | 3.5% | 65 | 1 | 2 | 1 M | Room | 0.5 | [ |
| Crab | 1 M | 50 | 1 | 6 | 1 M | 20 | 3 | [ |
| Shrimp | 1% | 65 | 1 | 1 | 0.5 M | Room | - | [ |
| Shrimp | 3% | 100 | 1 | 1 | 1 M | Room | 0.5 | [ |
| Shrimp | 4% | 100 | 1 | 1 | 5% | Room | - | [ |
* Reactant concentrations are expressed in molarity or w/v %.
Comparison of chitin production from different sources according to Tolaimate et al. [48].
| Source | Number of Deproteinization Baths | Number of Demineralization Baths | DA | |
|---|---|---|---|---|
| 0.3 M; NaOH 80 °C; 1 h | 0.55 M HCl; 25 °C; 2 h | |||
| Cirripedia | Anatife | 4 | 2 | 100 |
| Reptantia | Red crab | 3 | 5 | 97 |
| Marbled crab | 3 | 3 | 99 | |
| Spider crab | 3 | 3 | 96 | |
| Reptantia | Lobster | 3 | 3 | - |
| Crayfish | 7 | 3 | 100 | |
| slipper lobster | 3 | 2 | - | |
| Freshwater crayfish | 3 | 2 | - | |
| Natantia | Pink shrimp | 3 | 3 | 100 |
| Grey Shrimp | 2 | 2 | 100 | |
| Stomatopoda | Squilla | 3 | 3 | 100 |
| Cephalopoda | Squid | 2 | 2 | 100 |
Figure 213C NMR spectra for (A) chitin and chitosans (B) obtained by homogeneous reacetylation DA = 0.60; (C) commercial chitosan from Pronova DA = 0.2; (D) fully deacetylated chitin. Reproduced with permission from [90]. Copyright 2000 American Chemical Society.
Figure 31H-NMR spectrum of chitosan with DA~0.06 in D2O at pH~4, T = 85 °C and polymer concentration 5 g/L. Signals at 4.9 ppm is for H-1 of d-glucosamine unit, at 4.7 ppm is for H-1 of N-acetyl-d-glucosamine, at 3.2 ppm is for H-2 and at 2.1 ppm is for -CH3 of the acetyl group allowing to get DA.
Main applications of chitin and chitosan in pharmaceutical and biomedical domains.
| Forms | Applications |
|---|---|
| Beads | Drug delivery [ |
| Microspheres [ | Enzyme immobilization |
| Gene delivery vehicle [ | |
| Nanoparticles | Encapsulation of sensitive drugs [ |
| Coatings | Surface modification |
| Textile finishes | |
| Fibers | Medical textiles |
| Suture | |
| Nanofibers [ | Guided bone regeneration |
| Scaffold for nerve tissue regeneration | |
| Nonwonen bioactive fibers [ | Wound healing |
| Films | Wound care |
| Dialysis membrane | |
| Antitumoral [ | |
| Semi-permeable film for wound dressing [ | |
| Powder | Adsorbent for pharmaceutical and medical devices |
| Surgical glove powder | |
| Enzyme immobilization | |
| Sponge [ | Mucosomal hemostatic dressing |
| Wound dressing | |
| Drug delivery [ | |
| Enzyme entrapment | |
| Artificial skin [ | |
| Shaped objects | Orthopedics |
| Contact lenses | |
| Solutions | Cosmetics |
| Bacteriostatic agent | |
| Hemostatic agent | |
| Anticoagulants | |
| Antitumor agent | |
| Gene delivery [ | |
| Spermicide [ | |
| Gels | Delivery vehicle |
| Implants, coating | |
| Tissue engineering | |
| Wound dressing for wet treatment [ | |
| Tablets | Compressed diluent |
| Disintegrating agent | |
| Excipient [ | |
| Capsules | Delivery vehicle |